Targeting epidermal growth factor‐overexpressing triple‐negative breast cancer by natural killer cells expressing a specific chimeric antigen receptor
Cell Proliferation2020Vol. 53(8), pp. e12858–e12858
Citations Over TimeTop 10% of 2020 papers
Yan Liu, Yehui Zhou, Kuo‐Hsiang Huang, Xujie Fang, Ying Li, Feifei Wang, An Li, Qingfei Chen, Yunchao Zhang, Aihua Shi, Shuang Yu, Jingzhong Zhang
Abstract
This study suggested that treatment with EGFR-CAR NK cells could be a promising strategy for TNBC patients.
Related Papers
- → You Have Got a Fast CAR: Chimeric Antigen Receptor NK Cells in Cancer Therapy(2020)109 cited
- → Early and Late Toxicities of Chimeric Antigen Receptor T-Cells(2023)10 cited
- → Chimeric antigen receptor-redirected T cells return to the bench(2016)35 cited
- → [Prospect for chimeric antigen receptor-engineered T cell immunotherapy for solid tumors].(2018)
- → [Advances in Structural Designs of Chimeric Antigen Receptor T Cells--Review].(2022)